These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 31349905)
21. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763 [TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595 [TBL] [Abstract][Full Text] [Related]
24. Managing Squamous Cell Esophageal Cancer. Batra R; Malhotra GK; Singh S; Are C Surg Clin North Am; 2019 Jun; 99(3):529-541. PubMed ID: 31047040 [TBL] [Abstract][Full Text] [Related]
25. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma. Sun J; Song K; Feng X; Gao S Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997 [TBL] [Abstract][Full Text] [Related]
27. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma. Li J; Li M; Gao F; Ge X Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201 [TBL] [Abstract][Full Text] [Related]
28. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma. Sun N; Ye L; Chang T; Li X; Li X Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and treatment of early esophageal squamous cell carcinoma and precancerous lesions]. Xing J; Li P Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):318-321. PubMed ID: 32209201 [TBL] [Abstract][Full Text] [Related]
30. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
31. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related]
32. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance. Gulfidan G; Beklen H; Sinha I; Kucukalp F; Caloglu B; Esen I; Turanli B; Ayyildiz D; Arga KY; Sinha R OMICS; 2021 Aug; 25(8):495-512. PubMed ID: 34297901 [TBL] [Abstract][Full Text] [Related]
34. ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway. Yuan H; Zhou W; Yang Y; Xue L; Liu L; Song Y Exp Cell Res; 2018 Jun; 367(1):47-55. PubMed ID: 29555370 [TBL] [Abstract][Full Text] [Related]
35. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma. Kadian LK; Arora M; Prasad CP; Pramanik R; Chauhan SS Clin Transl Oncol; 2022 Jun; 24(6):1014-1032. PubMed ID: 34990001 [TBL] [Abstract][Full Text] [Related]
36. Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma. Wang Q; Zhang Q; Sun H; Tang W; Yang L; Xu Z; Liu Z; Jin H; Cao X Dig Dis Sci; 2019 Mar; 64(3):751-758. PubMed ID: 30519852 [TBL] [Abstract][Full Text] [Related]
37. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway. Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206 [TBL] [Abstract][Full Text] [Related]
38. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925 [TBL] [Abstract][Full Text] [Related]
39. Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection. Wang YL; Yuan Y; Luo XX; Hu GY; Gong P Curr Med Sci; 2019 Jun; 39(3):385-390. PubMed ID: 31209807 [TBL] [Abstract][Full Text] [Related]
40. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]